{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:38:38Z","timestamp":1770356318297,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1053\/j.semnuclmed.2011.07.004","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T13:33:40Z","timestamp":1322055220000},"page":"49-61","source":"Crossref","is-referenced-by-count":36,"title":["Imaging of the Thyroid in Benign and Malignant Disease"],"prefix":"10.1053","volume":"42","author":[{"given":"Charles M.","family":"Intenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Q.","family":"Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Manzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2011.07.004_bib1","first-page":"22","article-title":"Thyroid carcinoma presenting as a pertechnetate \u201chot\u201d nodule, but without 131I uptake: Case report","volume":"17","author":"Turner","year":"1976","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-93-1-28","article-title":"Clinical significance of thyroid-stimulatingantibody in Graves' disease","volume":"93","author":"Zakarija","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib3","series-title":"Nuclear Medicine: Diagnosis and Therapy","first-page":"959","article-title":"Radioiodine therapy of hyperthyroidism","author":"Harbert","year":"1996"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib4","first-page":"885","article-title":"Graves' disease with functioning nodules (Marine-Lenhart syndrome)","volume":"13","author":"Charkes","year":"1972","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/365649a0","article-title":"Somatic mutations in the thyrotropin receptorgene cause hyperfunctioning thyroid adenomas","volume":"365","author":"Parma","year":"1993","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib6","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1172\/JCI112199","article-title":"Pathogenesis of heterogeneity in humanmultinodular goiter","volume":"76","author":"Peter","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib7","series-title":"Thyroid Function and Disease","first-page":"179","article-title":"Subacute thyroiditis","author":"Volpe","year":"1989"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-104-2-219","article-title":"The various presentations of thyroiditis","volume":"104","author":"Hamburger","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archinte.1980.00330160038023","article-title":"Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis)","volume":"140","author":"Nikolai","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/rg.234025716","article-title":"Scintigraphic manifestations of thyrotoxicosis","volume":"23","author":"Intenzo","year":"2003","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib12","first-page":"1","article-title":"Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer 3.0","author":"Silberstein","year":"2006"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib14","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jcem.84.7.5827","article-title":"[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels","volume":"84","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-006-0341-x","article-title":"Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: A comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement","volume":"34","author":"Urhan","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12149-009-0303-z","article-title":"Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer","volume":"23","author":"Iwano","year":"2009","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003072-200201000-00001","article-title":"I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours","volume":"27","author":"Gerard","year":"2002","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1148\/radiol.2463061328","article-title":"Initial staging of differentiated thyroid carcinoma: Continued utility of posttherapy 131I whole-body scintigraphy","volume":"246","author":"Donahue","year":"2008","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.mnm.0000194397.20067.b6","article-title":"The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy","volume":"27","author":"Ali","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003072-200101000-00002","article-title":"Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer","volume":"26","author":"Mandel","year":"2001","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib21","first-page":"279","article-title":"The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases","volume":"27","author":"Yaakob","year":"1999","journal-title":"J Nucl Med Technol"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00259-002-0785-6","article-title":"Self-stunning in thyroid ablation: Evidence from comparative studies of diagnostic I-131 and I-123","volume":"29","author":"Hilditch","year":"2002","journal-title":"Eur J Nucl Med Mol Image"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.RLU.0000048678.96894.9A","article-title":"Comparison of I-123 and I-131 for whole-body imaging after stimulation by recombinant human thyrotropin: A preliminary report","volume":"28","author":"Anderson","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib24","first-page":"632","article-title":"Comparison of I-123 and I-131 for whole-body imaging in thyroid cancer","volume":"42","author":"Sarkar","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/thy.1994.4.49","article-title":"Influence of diagnostic radioiodines on the uptake of ablative dose of I-131","volume":"4","author":"Park","year":"1994","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2967\/jnumed.107.040311","article-title":"Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma","volume":"48","author":"Silberstein","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semnuclmed.2010.10.004","article-title":"Thyroid stunning: Fact or fiction?","volume":"41","author":"McDougall","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF02985956","article-title":"Diagnostic I-131 scintigraphy in patients with differentiated thyroid cancer: No additional value of higher scan dose","volume":"18","author":"Phan","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","article-title":"Current approaches to primary therapy for papillary and follicular thyroid cancer","volume":"88","author":"Mazzaferi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/thy.2008.0419","article-title":"The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroidology"},{"issue":"suppl","key":"10.1053\/j.semnuclmed.2011.07.004_bib32","first-page":"236P","article-title":"Quantitating the superiority of pinhole relative to parallel-hole collimator images in detecting foci of radioiodine uptake in the thyroid bed\/neck in patients with well-differentiated thyroid cancer","volume":"49","author":"Aiken","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/RLU.0b013e3181a345be","article-title":"Appropriate time for post-therapeutic I-131 whole body scan","volume":"34","author":"Hung","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib34","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1210\/jcem.87.4.8274","article-title":"Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment","volume":"87","author":"Pacini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.0.1500105","article-title":"Follow-up of low-risk patients with differentiated thyroid carcinoma: A European perspective","volume":"150","author":"Schlumberger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00259-011-1728-x","article-title":"One should not just read what one believes: The nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer","volume":"38","author":"Dietlein","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/thy.2009.1582","article-title":"The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer","volume":"19","author":"McDougall","year":"2009","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib38","first-page":"686","article-title":"Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer","volume":"38","author":"Carril","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/105072502753522356","article-title":"Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma","volume":"12","author":"Van Nostrand","year":"2002","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib40","year":"2010"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.mlg.0000154730.31281.0c","article-title":"Thyroglobulin before ablation and correlation with posttreatment scanning","volume":"115","author":"de Ros\u00e1rio","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/thy.2010.0145","article-title":"Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and I-131 activity in patients with thyroid cancer and low risk of recurrence","volume":"21","author":"Rosario","year":"2011","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.85.1.6310","article-title":"Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?","volume":"85","author":"Cailleux","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib44","first-page":"1470","article-title":"Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone","volume":"42","author":"David","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib45","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jcem.87.7.8702","article-title":"Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?","volume":"87","author":"Robbins","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/RLU.0b013e31818bf146","article-title":"Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: Predictive value and recommendations","volume":"33","author":"Tachi","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00259-008-0912-0","article-title":"Recurrent\/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans","volume":"36","author":"Park","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib48","first-page":"629","article-title":"Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma","volume":"78","author":"Sherman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003072-200412000-00005","article-title":"Post I-131 therapy scanning in patients with thyroid carcinoma metastases: An unnecessary cost or a relevant contribution?","volume":"29","author":"Souza Ros\u00e1rio","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/thy.2000.10.573","article-title":"Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?","volume":"10","author":"Fatourechi","year":"2000","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2011.07.004_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4158\/EP.4.1.11","article-title":"Use of iodine-123 as a diagnostic tracer for neck and whole-body scanning in patients with well-differentiated thyroid cancer","volume":"4","author":"Berbano","year":"1998","journal-title":"Endocr Pract"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129981100095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129981100095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T03:26:58Z","timestamp":1543375618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000129981100095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S000129981100095X"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2011.07.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}